- ►endojournals.org CW Chia, JM Egan - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Evidence Synthesis: Exenatide and liraglutide are injection based. Three-year follow-up data
on exenatide showed a sustained weight loss and glycosylated hemoglobin (HbA 1c ) reduction
of 1%. Nausea and vomiting are common. Results from phase 3 studies are pending on ... Cited by 24 - Related articles - All 5 versions
M Bose, B Olivan, J Teixeira, FX Pi-Sunyer, B Laferrere - Obesity Surgery, 2009 - Springer Page 1. REVIEW Do Incretins Play a Role in the Remission of Type 2 Diabetes after
Gastric Bypass Surgery: What are the Evidence? Mousumi Bose & Blanca Oliván
& Julio Teixeira & F. Xavier Pi-Sunyer & Blandine Laferrère ... Cited by 11 - Related articles - All 3 versions
- ►physiology.org K Begriche, P Letteron, A Abbey-Toby, N … - American Journal of …, 2008 - Am Physiological Soc Partial leptin deficiency is not uncommon in the general population. We hypothesized that leptin
insufficiency could favor obesity, nonalcoholic steatohepatitis (NASH), and other metabolic
abnormalities, particularly under high calorie intake. Thus, mice partially deficient in leptin ... Cited by 10 - Related articles - BL Direct - All 3 versions
M Kellerer - Der Diabetologe, 2009 - Springer Immer mehr Menschen erkranken an Typ-2-Diabetes. Durch die Identifikati- on unterschiedlicher
biochemischer Ri- sikofaktoren und die Analyse von Diabe- tesgenen wird versucht, ein besseres
Ver- ständnis für die Krankheitsentstehung zu gewinnen. Die genetische Charakterisie- ... Cited by 2 - Related articles
- ►eje.org J Vrbikova, M Hill, B Bendlova, T Grimmichova, K … - European Journal of …, 2008 - eje.org Objective: Polycystic ovary syndrome (PCOS) has been linked to a high risk of type 2 diabetes
mellitus. Disturbances in the secretion of the incretin hormones glucose-dependent insulinotropic
polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) have been observed in states with ... Cited by 1 - Related articles - All 8 versions
- ►ajcn.org PB Higgins, JR Fernandez, WT Garvey, WM … - American Journal of …, 2008 - Am Soc Nutrition 3 Supported by grants from the National Institutes of Health (R01-DK067426, P30-DK56336,
and M01-RR-00032) and the American Heart Association (0515149B). PBH was supported in
part by a predoctoral fellowship from the American Heart Association and a partial ... Cited by 1 - Related articles - All 4 versions
JJ Meier, MA Nauck - Nature clinical practice. Endocrinology & …, 2008 - ncbi.nlm.nih.gov 1: Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):606-7. Epub 2008 Aug 26. Is secretion of
glucagon-like peptide-1 reduced in type 2 diabetes mellitus? Meier JJ, Nauck MA. Department
of Medicine I, St Josef-Hospital, Ruhr-University Bochum, Germany. ... Cited by 1 - Related articles - All 3 versions
K Vollmer, H Gardiwal, BA Menge, O Goetze, … - Journal of Clinical …, 2009 - Endocrine Soc Introduction: Impaired secretion of glucagon-like peptide 1 (GLP-1) has been suggested to contribute
to the deficient incretin effect in patients with type 2 diabetes. It is unclear whether this is a primary
defect or a consequence of the hyperglycemia in type 2 diabetes. We examined whether ... Cited by 1 - Related articles - All 3 versions
MA Nauck - The American Journal of Medicine, 2009 - Elsevier Type 2 diabetes mellitus has become an enormous and worldwide healthcare problem that is
almost certain to worsen. Current therapies, which address glycemia and insulin resistance,
have not adequately addressed the complications and treatment failures associated with ... Cited by 2 - Related articles - All 39 versions
